YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence

Attempts to identify biomarkers to detect prostate tumorigenesis, and thus minimize prostate cancer progression and inform treatment decisions have primarily focused on alterations at the DNA and mRNA levels, ignoring alterations at the level of protein synthesis control. We have previously shown th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheridan, Christine Moore, Grogan, Tristan R., Nguyen, Hao G., Galet, Colette, Rettig, Matthew B., Hsieh, Andrew C., Ruggero, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480693/
https://www.ncbi.nlm.nih.gov/pubmed/25797255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480693/
https://www.ncbi.nlm.nih.gov/pubmed/25797255

Ejemplares similares